Info
Insider Ownership

Insider Trading & Ownership of Ran Frenkel

Location: Newton, MA
Summary: The estimated net worth of Ran Frenkel is at least $137,998 dollars as of 02 Mar 2022. Ran Frenkel is the EVP, Chief Dev. Officer of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $138K.
Signature: /s/ Nancy Smith as Attorney-in-Fact for Ran Frenkel
All Insider Reports: All Insider Reports

Notify me when Ran Frenkel files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Ran Frenkel

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
KPTI	Karyopharm Therapeutics Inc.	EVP, Chief Dev. Officer	$137,998			28 Feb 2022

Insider Transactions Reported by Ran Frenkel:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.